Lidocaine Patch Safety in Pediatric Patients

Introduction to Safety Considerations

The FDA approves topical lidocaine for children 2 years and older, but lidocaine patches should be used with extreme caution or avoided in patients weighing less than 40 kg due to increased risk of systemic toxicity 1

Most 3-year-old children weigh between 13-16 kg, placing them well below the 40 kg safety threshold for lidocaine patch use 2

Maximum safe dose of lidocaine without epinephrine is 4.4 mg/kg 2
A standard 5% lidocaine patch contains 700 mg of lidocaine, though systemic absorption is typically limited 1

Apply only to intact skin, never to mucosal surfaces or highly vascular areas where systemic absorption increases dramatically 2, 1
Limit application to the smallest effective surface area within manufacturer recommendations 2
Remove after 12 hours maximum, never use occlusive dressings 1
Do not use within 4 hours of any other local anesthetic intervention to prevent cumulative toxicity 1
Calculate total lidocaine exposure from all sources, including any topical creams or other preparations 2, 1

Document vital signs at least every 5 minutes initially when using in young children 2
Watch for early signs of toxicity: circumoral numbness, facial tingling, slurred speech, tinnitus, light-headedness 1
Seizures are often the first manifestation of local anesthetic systemic toxicity in children 2

Have 20% lipid emulsion immediately available before application 2
Treatment includes immediate ventilation with 100% oxygen, benzodiazepines for seizures, and lipid emulsion for cardiovascular collapse 2
Alert nearest facility with cardiopulmonary bypass capability 2

EMLA cream (lidocaine-prilocaine 5%) applied 30-60 minutes before procedures has extensive safety data in children over 12 months, though still requires careful dosing 3
Topical refrigerant (vapocoolant) spray is as effective as lidocaine-prilocaine cream for injection pain with minimal systemic absorption 3

Failing to calculate maximum allowable dose before application, particularly when patches are used with other local anesthetic interventions 2
Applying to highly vascular or mucosal surfaces where systemic absorption increases dramatically 2, 1
Combining with other sedatives or local anesthetics without considering additive effects and cumulative dosing 2
Using in children under 40 kg without exceptional justification and intensive monitoring 1